Objectives. Treatment of psychotic disorders is impended by high rates of disengagement from mental health services and poor adherence to antipsychotic medication. This study examined the engagement rates of psychotic patients with a community mental health service during a 5-year period. Methods. The Mobile Mental Health Unit of Ioannina and Thesprotia (MMHU I-T) delivers services in remote, rural, mountainous areas using the resources of the primary care system. Clinical and demographic information for patients with a diagnosis of schizophrenia and related psychoses was obtained from the medical records of our unit. Results. A total of 74 psychotic patients initially engaged in treatment with our unit. In half of cases treatment was home-based. With the exclusion of patients who died or discharged, engagement rates were 67.2%. Statistical analysis was performed for 64 patients, and no differences were found between engaged and disengaged patients regarding clinical and demographic parameters. All engaged patients regularly refilled their antipsychotic prescriptions. Conclusion. Engagement rates in our study were comparable to previous research, involving urban settings and shorter follow-up duration. Community mental health teams may ensure treatment continuation for psychotic patients in deprived, remote areas. This is important for low-income countries, affected by economic crisis, such as Greece. 1. Introduction Schizophrenia and related disorders are chronic and disabling and have a major impact on the person, the family, and the society in general. Continuity of care is considered essential in the effective management of such long-term disorders by service users, clinicians, and health care policy makers [1]. Previous studies have suggested that continuity of care is positively associated with health outcomes among persons with severe mental illness [2]. More recently, continuity of care was linked to better social functioning of people with chronic psychotic disorders [3]. However, despite the availability of effective pharmacological and psychosocial treatments for the management of psychotic disorders, treatment is impended by high rates of disengagement from mental health services and poor adherence to antipsychotic medication. Treatment discontinuation has severe consequences for the patients, such as relapse, hospitalization, homelessness, suicide, and violence [4, 5]. This may be particularly the case of psychotic patients living in poor and deprived remote rural areas who may not receive appropriate mental health care. Evidence from
References
[1]
T. Burns, J. Catty, S. White et al., “Continuity of care in mental health: understanding and measuring a complex phenomenon,” Psychological Medicine, vol. 39, no. 2, pp. 313–323, 2009.
[2]
C. Adair, G. McDougal, C. Mitton et al., “Continuity of care and health outcomes among persons with severe mental illness,” Psychiatric Services, vol. 56, no. 9, pp. 1061–1069, 2005.
[3]
J. Catty, S. White, S. Clement, et al., “Continuity of care for people with psychotic illness: its relationship to clinical and social functioning,” International Journal of Social Psychiatry, vol. 59, no. 1, pp. 5–17, 2013.
[4]
J. Kreyenbuhl, I. R. Nossel, and L. B. Dixon, “Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature,” Schizophrenia Bulletin, vol. 35, no. 4, pp. 696–703, 2009.
[5]
D. Novick, J. M. Haro, D. Suarez, V. Perez, R. W. Dittmann, and P. M. Haddad, “Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia,” Psychiatry Research, vol. 176, no. 2-3, pp. 109–113, 2010.
[6]
G. Thornicroft, M. Semrau, A. Alen, et al., Eds., Community Mental Health: Putting Policy into Practice Globally, Willey-Blackwell, New York, NY, USA, 2011.
[7]
M. Madianos, C. Zacharakis, C. Tsitsa, et al., “The mental health care delivery system in Greece: regional variation and socioeconomic correlates,” Journal of Mental Health Policy and Economics, vol. 2, no. 4, pp. 169–176, 1999.
[8]
V. Peritogiannis, C. Mantas, D. Alexiou, V. Fotopoulou, V. Mouka, and T. Hyphantis, “The contribution of a mobile mental health unit to the promotion of primary mental health in rural areas in Greece: a 2-year follow-up,” European Psychiatry, vol. 26, no. 7, pp. 425–427, 2011.
[9]
T. Burns, “Planning and providing mental health services for a community,” in New Oxford Textbook of Psychiatry, M. Gelder, N. Andreasen, J. J. Lopez-Ibor, and J. Geddes, Eds., pp. 1452–1462, Oxford University Press, New York, NY, USA, 2nd ed edition, 2009.
[10]
A. Mariolis, C. Mihas, A. Alevizos et al., “Comparison of primary health care services between urban and rural settings after the introduction of the first urban health centre in Vyronas, Greece,” BMC Health Services Research, vol. 8, p. 124, 2008.
[11]
A. O'Brien, R. Fahmy, and S. P. Singh, “Disengagement from mental health services: a literature review,” Social Psychiatry and Psychiatric Epidemiology, vol. 44, no. 7, pp. 558–568, 2009.
[12]
P. Masand, M. Roca, M. S. Turner, and J. M. Kane, “Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review,” Primary Care Companion to the Journal of Clinical Psychiatry, vol. 11, no. 4, pp. 147–154, 2009.
[13]
S. Brown, H. Inskip, and B. Barraclough, “Causes of the excess mortality of schizophrenia,” British Journal of Psychiatry, vol. 177, pp. 212–217, 2000.
[14]
S. Simmonds, J. Coid, P. Joseph, S. Marriott, and P. Tyrer, “Community mental health team management in severe mental illness: a systematic review,” British Journal of Psychiatry, vol. 178, pp. 497–502, 2001.
[15]
R. G. McCreadie, M. Leese, D. Tilak-Singh, L. Loftus, T. Macewan, and G. Thornicroft, “Nithsdale, Nunhead and Norwood: similarities and differences in prevalence of schizophrenia and utilisation of services in rural and urban areas,” British Journal of Psychiatry, vol. 170, pp. 31–36, 1997.
[16]
I. Harrison, E. M. Joyce, S. H. Mutsatsa et al., “Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study,” Psychological Medicine, vol. 38, no. 1, pp. 79–88, 2008.
[17]
J. Haro, E. Edgell, P. Frewer, J. Alonso, and P. B. Jones, “The European schizophrenia outpatient health outcomes study: baseline findings across country and treatment,” Acta Psychiatrica Scandinavica, vol. 107, supplement 416, pp. 7–15, 2003.
[18]
J. Lieberman, T. Scott Stroup, J. P. McEvoy et al., “Effectiveness of antipsychotic drugs in patients with chronic schizophrenia,” New England Journal of Medicine, vol. 353, no. 12, pp. 1209–1223, 2005.
[19]
R. Kahn, W. W. Fleischhacker, H. Boter et al., “Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial,” The Lancet, vol. 371, no. 9618, pp. 1085–1097, 2008.
[20]
J. Lacro, L. Dunn, C. Dolder, S. G. Leckband, and D. V. Jeste, “Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature,” Journal of Clinical Psychiatry, vol. 63, no. 10, pp. 892–909, 2002.
[21]
T. Burns, “The rise and fall of assertive community treatment,” International Review of Psychiatry, vol. 22, no. 2, pp. 130–137, 2010.
[22]
A. Kentikelenis, M. Karanikolos, I. Papanicolas, S. Basu, M. McKee, and D. Stuckler, “Health effects of financial crisis: omens of a Greek tragedy,” The Lancet, vol. 378, no. 9801, pp. 1457–1458, 2011.
